Titlebook: Clinical Cellular Immunology; Molecular and Therap Albert A. Luderer,Howard H. Weetall Book 1982 The HUMANA Press Inc. 1982 Antigen.Immune

易發(fā)怒

思鄉(xiāng)病

The T Cell Antigen Receptor,ssociated receptors found on the cell surface of lymphocytes. Certainly the interaction of antigen with both regulatory and effector thymus-derived lymphocytes (T cells) is a critical event in this process. According to clonal selection theories (Burnett, 1969), antigen initially interacts with a re

ATOPY

Fortify

Immunosuppressive Agents,he disease, and each has its benefits and risks. Although radiotherapy and chemotherapy have the advantage of reaching tumors and cells that are inaccessible to surgery (or, because of their location or wide dissemination, that cannot be surgically removed), these forms of treatment may exert damagi

昏迷狀態(tài)

,The Immunobiology of Human Non-Hodgkin’s Lymphomas,ly expanding knowledge of immunocytes has been applied to this spectrum of diseases and has resulted in more scientifically accurate classifications. Of perhaps greater import, however, is the nascent realization that these diseases represent malignant counterparts of normal lymphocyte development,

browbeat

Cell-Mediated Immunity in Autoimmune Disease,wing infection by tubercle bacilli. Dienes many years later (1936) was the first to consider delayed hypersensitivity as an independent branch of the immunological response rather than a unique response to infectious microorganisms. He was successful in producing delayed hypersensitivity by injectin

Promotion

Cell-Mediated Immunity in Tumor Rejection,nt. Although much effort was initially expended concerning humoral immune mechanism in malignancy, many studies over the last decade or so have focused attention mainly on cell-mediated immune (CMI) interactions of the host with tumors. It is, however, quite apparent that such CMI reactions are high

STALL

水汽

Immunologic Tests for Diagnosis and Monitoring of Defects in Cell-Mediated Immunity,agnosis and more precise definition of clinical immunodeficiencies. The definition of particular defects by immunological and biochemical means has in addition led to the development of rational therapeutic approaches, such as replacement therapy and immunomodulation (Fudenberg and Wybran, 1980). Ad

饑荒

8樓